A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy
NCT ID: NCT02769780
Last Updated: 2022-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2015-07-08
2021-08-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Nexus website: www.narcolepsyregistry.com
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nexus Compliance Study
NCT01013207
Data Collection Study to Review Novel Methods for Diagnosing Obstructive Sleep Apnea
NCT06930404
Autonomic Function in Obstructive Sleep Apnea
NCT00681161
Investigating the Neuropathology of Obstructive Sleep Apnoea
NCT02967536
Obstructive Sleep Apnoea in Patients With Intermittent Claudication
NCT01801592
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with narcolepsy by a doctor
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Invitae Corporation
INDUSTRY
Wake Up Narcolepsy
UNKNOWN
Narcolepsy Network
UNKNOWN
ICON plc
INDUSTRY
Jazz Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danielle Hyman, PhD
Role: STUDY_DIRECTOR
Jazz Pharmaceuticals
JeanPierre Coaquira, MPH
Role: PRINCIPAL_INVESTIGATOR
Jazz Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jazz Pharmaceuticals
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Thorpy MJ, Ohayon MM, Carls G, Black J, Pasta DJ, Hyman DL, Villa KF. Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus Narcolepsy Registry (waves 1-4). Sleep Med. 2021 Aug;84:380-388. doi: 10.1016/j.sleep.2021.06.010. Epub 2021 Jun 19.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nexus Narcolepsy Registry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.